Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2020 / N 2

Выбор тактики лечения для пациента с дорсалгией
П.Р. Камчатнов, Б.А. Абусуева, С.Б. Ханмурзаева

References

1. Jin Z, Wang D, Zhang H, Liang J, Feng X, Zhao J, Sun L. Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the Global Burden of Disease study 2017. Annals of the Rheumatic Diseases 2020 May 15;annrheumdis-2020-217050. doi: 10.1136/annrheumdis-2020-217050. Online ahead of print.
2. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics. Ambulatory Medical Care Survey: 2010 summary tables. Table 9. Twenty leading principal reasons for office visits, by patient’s sex: United States, 2010. Available from: www.cdc.gov/nchs/data/ahcd/namcs_summary/ 2010_namcs_ web_tables.pdf Accessed 2020 Jun 25.
3. Canizares M, Rampersaud YR, Badley EM. Course of back pain in the Canadian population: trajectories, predictors, and outcomes. Arthritis Care & Research 2019 Dec;71(12):1660-70.
4. Wu A, March L, Zheng X, Huang J, Wang X, Zhao J, Blyth F, Smith E, Buchbinder R, Hoy D. Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017. Annals of Translational Medicine 2020 Mar;8(6):299.
5. Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, Williams G, Smith E, Vos T, Barendregt J, Murray C, Burstein R, Buchbinder R. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases 2014 Jun;73(6):968-74.
6. Yesin RG, Yesin OR, Akhmadeyeva GD, Salikhova GV, Back pain. Kazan, 2010; 272 p. (In Russian).
7. Parfenov VA, Yakhno NN, Davydov OS, Kukushkin ML, Churyukanov MV, Golovacheva VA, Isaykin AI, Achkasov EE, Yevzikov GYu, Karateyev AE, Khabirov FA, Shirokov VA, Yakupov EZ. Chronic non-specific (musculoskeletal) low back pain. Guidelines of the Russian Society for the Study of Pain (RSSP). Neurology, Neuropsychiatry, Psychosomatics 2019;11(S1):7-16 (In Russian).
8. Park PW, Dryer RD, Hegeman-Dingle R, Mardekian J, Zlateva G, Wolff GG, Lamerato L. Cost burden of chronic pain patients in a large integrated delivery system in the United States. Pain Practice 2016 Nov;26(8):1001-11.
9. Tsuji T, Matsudaira K, Sato H, Vietri J, Jaffe DH. Association between presenteeism and health-related quality of life among Japanese adults with chronic lower back pain: a retrospective observational study. BMJ Open 2018 Jun;8(6):e021160.
10. Ita ME, Zhang S, Holsgrove TP, Karta S, Winkelstein BA. The physiological basis of cervical facet-mediated persistent pain: basic science and clinical challenges. The Journal of Orthopaedic & Sports Physical Therapy 2017 Jul;47(7):450-61.
11. Maher C, Underwood M, Buchbinder R. Non-specific low back pain. The Lancet 2017 Feb;389(10070):736-47.
12. Wong JJ, Côté P, Sutton DA, Randhawa K, Yu H, Varatharajan S, Goldgrub R, Nordin M, Gross DP, Shearer HM, Carroll LJ, Stern PJ, Ameis A, Southerst D, Mior S, Stupar M, Varatharajan T, Taylor-Vaisey A. Clinical practice guidelines for the noninvasive management of low back pain: a systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. European Journal of Pain (London, England) 2017 Feb;21(2):201-16.
13. Cutforth G, Peter A, Taenzer P. The Alberta Health Technology Assessment (HTA) ambassador program: the development of a contextually relevant, multidisciplinary clinical practice guideline for non-specific low back pain: a review. Physiotherapy Canada 2011 Summer;63(3):278-86.
14. Livingston C, King V, Little A, Pettinari C, Thielke A, Gordon C. State of Oregon Evidence-based Clinical Guidelines Project. Evaluation and management of low back pain: a clinical practice guideline based on the joint practice guideline of the American College of Physicians and the American Pain Society (diagnosis and treatment of low back pain). Salem: Office for Oregon Health Policy and Research. October 2011. Available from: http://www.oregon.gov/OHA/OHPR/HERC/Evidence-Based-Guidelines.shtml Accessed 2020 Jun 25.
15. Wood L, Hendrick PA. A systematic review and meta-analysis of pain neuroscience education for chronic low back pain: short- and long-term outcomes of pain and disability. European Journal of Pain (London, England) 2019 Feb;23(2):234-49.
16. Roelofs PDD, Deyo RA, Koes BW, Scholten RJPM, van Tulder MW. Nonsteroidal anti-inflammatory drugs for low back pain. An updated Cochrane review. Spine (Philadelphia, Pa 1976) 2008 Jul;33(16):1766-74.
17. Spofford CM, Ashmawi H, Subieta A, Buevich F, Moses A, Baker M, Brennan TJ. Ketoprofen produces modality-specific inhibition of pain behaviors in rats after plantar incision. Anesthesia & Analgesia 2009 Dec;109(6):1992-9.
18. Sarzi-Puttini P, Atzeni F, Lanata L, Bagnasco M. Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis. Clinical and Experimental Rheumatology 2013;31(5):731-8.
19. Gouveia N, Rodrigues A, Ramiro S, Eusébio M, Machado PM, Canhão H, Branco JC. The use of analgesic and other pain-relief drugs to manage chronic low back pain: results from a national survey. Pain Practice 2017 Mar;7(3):353-65.
20. Riou B, Plaisance P, Lecomte F, Soulat L, Orcel P, Mazoit JX. Comparison of two doses of ketoprofen to treat pain: a double-blind, randomized, noninferiority trial. Fundamental & Clinical Pharmacology 2014 Feb;28(1):20-8.
21. Fedin AI, Batysheva TT, Vinetskiy YaYa, Kozlov MYu. Ketonal in treatment of acute dorsalgia. Treatment of Nervous Diseases 2002;2(7):27-9 (In Russian).
22. Boyko AN, Trubetskaya EA, Kamchatnov PR, Khozova AA, Petrov SV, Otcheskaya OV, Ganzhula PA. Efficacy of ketoprofen lysine salt (artrosilene) in treatment of nonspecific vertebrogenic pain syndromes in outpatients. SS Korsakov Journal of Neurology and Psychiatry 2013;113(1):53-5 (In Russian).
23. Nissen SE, Yeomans N, Solomon D, Lüscher T, Libby P, Husni M, Graham D, Borer J, Wisniewski L, Wolski K, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B, Berger MF, Bao W, Lincoff AM; PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. The New England Journal of Medicine 2016 Dec;375(26):2519-29.
24. Matsumoto AK, Cavanaugh PE Jr. Etoricoxib. Drugs of Today (Barcelona, Spain: 1998) 2004 May;40(5):395-414.
25. Martina SD, Vesta KS, Ripley TL. Etoricoxib: a highly selective COX-2 inhibitor. The Annals of Pharmacotherapy 2005 May;39(5):854-62.
26. Bingham CO III, Sebba AI, Rubin BR, Ruo GE, Kremer J, Bird S, Smugar S, Fitzgerald BJ, O’Brien K, Tershakovec AM. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology 2007 Mar;46(3):496-507.
27. Yoo MC, Yoo WH, S Kang SB, Park YW, Kim SS, Moon KH, Song YW, Min BW, Cho YJ, Moon SH, Bin SI, Baek HJ, Shim SC, Lee SW, Yoo DH, Mehta A, Skuban A, Cukrow DM, Vandormael K, Yan L. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial. Current Medical Research and Opinion 2014 Dec;30:2399-408.
28. Curtis SP, Bockow B, Fisher C, Olaleye J, Compton A, Ko AT, Reicin AS. Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial (NCT 00242489). BMC Musculoskeletal Disorders 2007 Dec;6:58.
29. Song GG, Seo YH, Kim JH, Choi SJ, Ji JD, Lee YH. Relative efficacy and tolerability of etoricoxib, celecoxib, and naproxen in the treatment of osteoarthritis: a Bayesian network meta-analysis of randomized controlled trials based on patient withdrawal. Zeitschrift für Rheumatologie 2016 Jun;75(5):508-16.
30. Kamchatnov PR. Improving the efficacy and safety of treatment of patients with low back pain. SS Korsakov Journal of Neurology and Psychiatry 2016;116(10):28-33 (In Russian).
31. Qaseem A, Wilt TJ, McLean RM, Forciea MA; Clinical Guidelines Committee of the American College of Physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine 2017 Apr;166(7):514-30.
32. Tao Y, Gu J, Stephens R Jr. Role of spinal cord glutamate transporter during normal sensory transmission and pathological pain states. Molecular Pain 2005;1:30-7.
33. Ghanavatian S, Derian A. Tizanidine. Treasure Island (FL): StatPearls Publishing; 2019.
34. Pareek A, Chandurkar N, Chandanwale AS, Ambade R, Gupta A, Bartakke G. Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone. European Spine Journal 2009 Dec;18(12):1836-42.
35. Malanga GA, Gwynn MW, Smith R, Miller D. Tizanidine is effective in the treatment of myofascial pain syndrome. Pain Physician 2002 Oct;5(4):422-32.
36. Jain NK, Kulkarni SK, Singh A. Modulation of NSAID-induced antinociceptive and anti-inflammatory effects by alpha2-adrenoceptor agonists with gastroprotective effects. Life Sciences 2002 May;70(24):2857-69.
37. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for non-specific low-back pain. The Cochrane Database of Systematic Reviews 2003 Apr;2003(2):CD004252.
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]